Saturday, July 17, 2004

Chief Executive is the Head Innovator at Novartis

Chief Executive - Innovation: July 2004 Issue 200: "Many experts agree that in an industry where the work is as technical as pharmaceuticals, it helps if the CEO is a scientist or doctor."

The article above describes the technical prowess, technical management, and technical interests of the CEO of Novartis ... almost as if he were the CTO. He seems to set R&D budgets based on his own understanding of the potential of each new drug. Novartis does not have a CTO, but Jorg Reinhardt is the Head of Development, which includes R&D. What input does he have on setting R&D budgets?


Post a Comment

Subscribe to Post Comments [Atom]

<< Home